GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Short Interest

BITGF (Biotage AB) Short Interest


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Biotage AB's Short Interest

For the Medical Instruments & Supplies subindustry, Biotage AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Biotage AB's Short Interest falls into.


';

Biotage AB Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB Headlines

From GuruFocus

Biotage AB (publ) Interim report January-September 2020

By PRNewswire PRNewswire 11-05-2020

Biotage Awarded Gold Sustainability Medal by EcoVadis

By PRNewswire PRNewswire 02-24-2022

Q4 2024 Biotage AB Earnings Call Transcript

By GuruFocus News 02-20-2025

Biotage appoints Nomination Committee

By PRNewswire PRNewswire 09-24-2020

Q3 2024 Biotage AB Earnings Call Transcript

By GuruFocus News 10-24-2024

Biotage moves to the large cap segment

By PRNewswire PRNewswire 01-03-2022

Biotage AB (publ) Interim report January - March 2021

By PRNewswire PRNewswire 04-28-2021

Q4 2023 Biotage AB Earnings Call Transcript

By GuruFocus Research 02-28-2024

Biotage AB (publ) Interim report January - September 2021

By PRNewswire PRNewswire 10-28-2021

Biotage AB (publ) appoints new CFO

By PRNewswire PRNewswire 07-01-2021